Synthesis and anticancer activity evaluation of ( E )-3-{[5-(aryl)-1,3,4-oxadiazol-2-yl]methyl}-5-(3,4,5-trimethoxybenzylidene)thiazolidine-2,4-diones

D. Ashok; B. Vanaja

doi:10.1134/S1070363216030270

Synthesis and anticancer activity evaluation of (E)-3-{[5-(aryl)-1,3,4-oxadiazol-2-yl]methyl}-5-(3,4,5-trimethoxybenzylidene)thiazolidine-2,4-diones

Autores: Ashok D.¹, Vanaja B.¹
Afiliações:
1. Green and Medicinal Chemistry Laboratory, Department of Chemistry
Edição: Volume 86, Nº 3 (2016)
Páginas: 681-685
Seção: Article
URL: https://journals.rcsi.science/1070-3632/article/view/214366
DOI: https://doi.org/10.1134/S1070363216030270
ID: 214366

Citar

Texto integral

Acesso aberto
Acesso é fechado

Acesso está concedido
Acesso é fechado

Somente assinantes

Resumo
Sobre autores
Bibliografia
Estatísticas

Resumo

A series of new substituted (E)-3-{[5-(aryl)-1,3,4-oxadiazol-2-yl]methyl}-5-(3,4,5-trimethoxy-benzylidene) thiazolidine-2,4-diones have been synthesized. The products have been characterized by their IR, ¹H NMR, ¹³C NMR, and mass spectral properties and evaluated for anticancer activity against four human cancer cell lines: A549, A375, MCF-7, and HT-29.

Palavras-chave

1,3,4-oxadiazole, thiazolidine-2,4-dione, cytotoxicity

Sobre autores

D. Ashok

Green and Medicinal Chemistry Laboratory, Department of Chemistry

Autor responsável pela correspondência
Email: ashokdou@gmail.com
Índia, Hyderabad, 500007

B. Vanaja